3,105
Views
9
CrossRef citations to date
0
Altmetric
Editorial

An unsound AAN Practice Advisory on poststroke etanercept

Pages 215-217 | Received 26 Nov 2016, Accepted 11 Jan 2017, Published online: 20 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Edward Tobinick. (2018) Perispinal etanercept advances as a neurotherapeutic. Expert Review of Neurotherapeutics 18:6, pages 453-455.
Read now

Articles from other publishers (6)

Ian A. Clark & Bryce Vissel. (2023) Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease. Pharmacology Research & Perspectives 11:5.
Crossref
Ian Albert Clark. (2022) Chronic cerebral aspects of long COVID, post‐stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic. Pharmacology Research & Perspectives 10:2.
Crossref
Ian A. Clark. (2021) How diseases caused by parasites allowed a wider understanding of disease in general: my encounters with parasitology in Australia and elsewhere over the last 50 years. International Journal for Parasitology 51:13-14, pages 1265-1276.
Crossref
I.A. Clark & B. Vissel. (2021) Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches. Journal of Alzheimer's Disease 79:3, pages 931-948.
Crossref
I A Clark & B Vissel. (2018) Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases. British Journal of Pharmacology 175:20, pages 3859-3875.
Crossref
Edward L. Tobinick, Tracey A. Ignatowski & Robert N. Spengler. 2017. Mechanisms of Neuroinflammation. Mechanisms of Neuroinflammation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.